In context
In mid-2024, laboratory automation was advancing rapidly, but regulated environments such as pharma and clinical labs demanded verifiable and traceable robotic actions—a gap that most commercial robots did not fill. The TraceBot project, funded under the EU's H2020 programme, aimed to address this by integrating traceability into robot manipulation.
What was reported
On 26–27 June 2024, the TraceBot consortium presented its project at the Future Labs Live trade fair in Basel, Switzerland. TraceBot is designed to develop laboratory robots that meet traceability criteria, making them suitable for environments with high safety and flexibility requirements.
The project's objective is to enable verifiable actions in robot manipulation by reasoning over sensor-actor trails within a traceability framework based on digital-twin technology. It extends current robot motion planners with automatic execution of self-checking procedures that create a semantic trace of performed actions.
The goal is to create robotic systems that understand what they perceive and do, ensuring every manipulation action is verified—critical for regulated environments. The project targets companies of all sizes, from SMEs to multinational corporations, offering an intelligent robot solution that integrates easily into existing laboratory facilities.
Why it mattered
TraceBot represented a step toward the automated laboratory of the future, where robots can be trusted to operate in regulated settings. By embedding traceability and self-checking into robot control, it addressed a key barrier to wider adoption of lab automation, potentially influencing broader industrial automation where verification is essential.
“The goal is to create robotic systems able to understand what they perceive and do, to ensure that any manipulation action is verified, thus meeting the needs of the regulated environment.”
Source: Robotics & Automation News (roboticsandautomationnews.com) · Published 2024-07-02 · “Consortium presents TraceBot at Future Labs Live”